Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [98ca6b8c-fb21-4ad3-8f5e-a014d22d26e1] => Array ( [runtime-id] => 98ca6b8c-fb21-4ad3-8f5e-a014d22d26e1 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [ee9d7375-ce4d-4000-b4c5-d22592ce3bef] => Array ( [runtime-id] => ee9d7375-ce4d-4000-b4c5-d22592ce3bef [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;568e510d8acd9bf6b7d717928008b870a724bf1d ) ) ) 1naresh2naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [98ca6b8c-fb21-4ad3-8f5e-a014d22d26e1] => Array
        (
            [runtime-id] => 98ca6b8c-fb21-4ad3-8f5e-a014d22d26e1
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [ee9d7375-ce4d-4000-b4c5-d22592ce3bef] => Array
                        (
                            [runtime-id] => ee9d7375-ce4d-4000-b4c5-d22592ce3bef
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;568e510d8acd9bf6b7d717928008b870a724bf1d
                )

        )

)

Table 1: Overall characteristics
Characteristics No.
Total studies 2003
Location 
    University of New Mexico 139 (6.9%)
    University of Pennsylvania 170 (8.5%)
    University of Pittsburgh 649 (32%)
    Stanford 710 (35%)
    Baylor College of Medicine 236 (12%)
    Medical College of Wisconsin 82 (4%)
    Medical College of Virginia 17 (0.8%)
Mechanically ventilated 517 (25.8%)
Chemically paralyzed 211 (40.7% of ventilated)
Nonventilated 1486 (74.2%)
Indication (some studies listed several) 
    Occlusive vascular disease 705 (35%)
    Ischemic stroke 537 (27%)
    Traumatic brain injury 323 (16%)
    Vasospasm after subarachnoid hemorrhage 271 (14%)
    Hemorrhagic stroke 96 (4.8%)
    Skull base aneurysm or tumor 62 (3.1%)
    Epilepsy 5 (0.2%)
    Brain tumor 3 (0.15%)
    Dementia 2 (0.1%)
    Hydrocephalus 1 (0.05%)
    Other 6 (0.3%)

Characteristics	No.
Total studies	2003
Location
University of New Mexico	139 (6.9%)
University of Pennsylvania	170 (8.5%)
University of Pittsburgh	649 (32%)
Stanford	710 (35%)
Baylor College of Medicine	236 (12%)
Medical College of Wisconsin	82 (4%)
Medical College of Virginia	17 (0.8%)
Mechanically ventilated	517 (25.8%)
Chemically paralyzed	211 (40.7% of ventilated)
Nonventilated	1486 (74.2%)
Indication (some studies listed several)
Occlusive vascular disease	705 (35%)
Ischemic stroke	537 (27%)
Traumatic brain injury	323 (16%)
Vasospasm after subarachnoid hemorrhage	271 (14%)
Hemorrhagic stroke	96 (4.8%)
Skull base aneurysm or tumor	62 (3.1%)
Epilepsy	5 (0.2%)
Brain tumor	3 (0.15%)
Dementia	2 (0.1%)
Hydrocephalus	1 (0.05%)
Other	6 (0.3%)